The Combination of Resveratrol and Quercetin Attenuates Metabolic Syndrome in Rats by Modifying the Serum Fatty Acid Composition and by Upregulating SIRT 1 and SIRT 2 Expression in White Adipose Tissue
Table 1
The effects of RSV + QRC administration on body characteristics and biochemical parameters from control and MetS rats.
Control
MetS
Without treatment
RSV 10 + QRC 0.19 mg/kg/day
RSV 50 + QRC 0.95 mg/kg/day
Without treatment
RSV 10 + QRC 0.19 mg/kg/day
RSV 50 + QRC 0.95 mg/kg/day
Body weight (g)
502.0 ± 19.5
463.8 ± 20.8
514.2 ± 20.9
570.4 ± 13.4a
490.8 ± 11.6c
489.8 ± 10.5c
Central adiposity (g)
6.0 ± 0.7
4.5 ± 0.6
6.3 ± 0.9
12 ± 0.6a
11.5 ± 0.9
8.9 ± 1.1c
Blood pressure (mm Hg)
103.3 ± 1.0
101.2 ± 2.7
108.4 ± 3.5
140.5 ± 1.0a
122.7 ± 3.8c
115.5 ± 2.9c
Glucose (mg/dL)
119.9 ± 12.2
118.8 ± 13.7
87.9 ± 5.9
121.8 ± 20.3
85.3 ± 9.5
90.7 ± 7.7
Insulin (ng/mL)
0.26 ± 0.02
0.25 ± 0.05
0.18 ± 0.04
0.47 ± 0.04a
0.29 ± 0.05c
0.23 ± 0.02c
HOMA-IR
1.3 ± 0.2
0.61 ± 0.03
0.9 ± 0.12
2.1 ± 0.3b
0.9 ± 0.1c
0.81 ± 0.1c
Leptin (ng/mL)
2.3 ± 0.3
3.3 ± 0.3
2.6 ± 0.1
4.2 ± 0.3a
5.2 ± 0.3d,e
3.8 ± 0.3e
Adiponectin (g/mL)
3.8 ± 0.2
4.2 ± 0.3
3.7 ± 0.3
6.7 ± 0.3a
6.1 ± 0.5e
5.8 ± 0.2e
Values are mean ± SEM. HOMA-IR: homeostatic model assessment of insulin resistance; ; MetS without treatment versus control without treatment; MetS without treatment versus control without treatment; against same group without treatment; versus same group with different doses; against control with same dose.